News Detail
Maryland, 3 Aug 2023: The US Food and Drug Administration (FDA) has reprimanded two drugmakers — Avlon Industries based in Melrose Park, Illinois, and Medgel based in Pithampur, Madhya Pradesh, India — over identity testing and other good manufacturing practice (......
View Details
Source : Regulatory Focus
US Food and Drug Administration (FDA)
Avlon Industries Melrose Park Illinois
Medgel based in Pithampur
good manufacturing practice (GMP) lapses
diethylene glycol (DEG) or ethylene glycol (EG) contamination
Related News
- AI can make drug-testing more precise, relevant to human biology (14-02-2025)
- Ayurvedic 'STONE NILL DS Syrup' claiming to treat 'Kidney Stones - Renal Calculi and Urethral Calculi' seized (14-02-2025)
- ED raids Niti Sen Bhatia's residence in Panipat (14-02-2025)
- Draft Guidelines for Processing Patent Applications of AYUSH Systems and Related Inventions (13-02-2025)
- FDA cracks down on online sale of MTP kits in Ghaziabad and Badaun, 227 seized (13-02-2025)
- Nepalese youth arrested with large quantity of drugs (13-02-2025)
- Seizure of Prohibited Drug Tablets in Pali (13-02-2025)
- Cosmetics with high methanol content seized in Kochi; used as aftershave (13-02-2025)
- ‘Sodium Phosphates Enema BP,’ claimed to treat ‘Convulsions’ seized (12-02-2025)
- Substandard Medicines issue raised in Rajya Sabha (12-02-2025)